Viewing Study NCT06465069


Ignite Creation Date: 2025-12-24 @ 10:52 PM
Ignite Modification Date: 2026-02-13 @ 8:48 AM
Study NCT ID: NCT06465069
Status: RECRUITING
Last Update Posted: 2025-12-22
First Post: 2024-06-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Sponsor: Eli Lilly and Company
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Solid Tumor View
None Recurrent Solid Tumor View
None Advanced Solid Tumor View
None Urinary Bladder Neoplasm View
None Triple Negative Breast Cancer View
None Non-small Cell Lung Cancer View
None Esophageal Cancer View
None Pancreatic Cancer View
None Ovarian Cancer View
None Cervical Cancer View
None Head and Neck Squamous Cell Carcinoma View
None Prostate Cancer View
None Renal Pelvis Cancer View
None Bladder Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Bladder Cancer View
None Bladder Neoplasm View
None Bladder Urothelial Carcinoma View
None Urinary Bladder Cancer View
None Urinary Tract Cancer View
None Urothelial Neoplasms View
None Renal Pelvis Cancer View
None Ureter Cancer View
None Nectin-4 View
None Antibody Drug Conjugate (ADC) View
None Triple Negative Breast Cancer (TNBC) View
None Non-small Cell Lung Cancer (NSCLC) View
None Head and Neck Squamous Cell Carcinoma (HNSCC) View